Source: Nextech AR Solutions.
  • Nextech AR Solutions (NTAR) has announced a marketed public offering for gross proceeds of up to $3,000,000
  • The company will issue up to 3.6 million units priced at $0.83 per unit
  • Net proceeds will be used for working capital and general corporate purposes
  • Nextech AR Solutions is a metaverse company active in augmented reality, 3D modelling, holograms and 360° portals
  • Nextech (NTAR) opened trading at C$0.81

Nextech AR Solutions (NTAR) has announced a marketed public offering for gross proceeds of up to $3,000,000.

The company will issue up to 3.6 million units priced at $0.83 per unit. Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one additional common share at a price of $1.15 for a period of four years.

The offering is being led by Research Capital Corporation as the sole agent and sole bookrunner.

The agents have been granted an over-allotment option, exercisable at any time and from time to time up to 30 days following the closing of the offering.

Net proceeds will be used for working capital and general corporate purposes.

The offering is expected to close on or about January 31, 2023, and is subject to all necessary regulatory approvals.

Nextech AR Solutions is a metaverse company active in augmented reality, 3D modelling, holograms and 360° portals.

Nextech AR Solutions (NTAR) opened trading at C$0.81.


More From The Market Online
Neon lights winding around city roads.

Transportation technology stock secures second major contract in a week

Transpo tech stock Quarterhill (TSX:QTRH) just signed a major contract to help improve road safety and foster the regulatory environment.
Sol Strategies CEO, Leah Wald

Solana-focused Sol Strategies attracts institutional capital

Global blockchain investor ParaFi Capital will allocate C$27.5 million into Solana-focused crypto operation Sol Strategies (CSE:HODL).
SurgiClear antimicrobial clear silicone adhesive dressing with chlorhexidine and silver

Covalon Technologies posts third profitable quarter in a row

Covalon Technologies (TSXV:COV), a healthcare technology stock, achieves net income profitability for the third straight quarter in Q4 2024.